Skip to main content
Top
Published in: Gastric Cancer 1/2013

Open Access 01-01-2013 | Special Article

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry

Authors: Atsushi Nashimoto, Kohei Akazawa, Yoh Isobe, Isao Miyashiro, Hitoshi Katai, Yasuhiro Kodera, Shunichi Tsujitani, Yasuyuki Seto, Hiroshi Furukawa, Ichiro Oda, Hiroyuki Ono, Satoshi Tanabe, Michio Kaminishi

Published in: Gastric Cancer | Issue 1/2013

Login to get access

Abstract

Background

The Japanese Gastric Cancer Association (JGCA) started a new nationwide gastric cancer registration in 2008.

Methods

From 208 participating hospitals, 53 items including surgical procedures, pathological diagnosis, and survival outcomes of 13,626 patients with primary gastric cancer treated in 2002 were collected retrospectively. Data were entered into the JGCA database according to the JGCA classification (13th edition) and UICC TNM classification (5th edition) using an electronic data collecting system. Finally, data of 13,002 patients who underwent laparotomy were analyzed.

Results

The 5-year follow-up rate was 83.3 %. The direct death rate was 0.48 %. UICC 5-year survival rates (5YEARSs)/JGCA 5YEARSs were 92.2 %/92.3 % for stage IA, 85.3 %/84.7 % for stage IB, 72.1 %/70.0 % for stage II, 52.8 %/46.8 % for stage IIIA, 31.0 %/28.8 % for stage IIIB, and 14.9 %/15.3 % for stage IV, respectively. The proportion of patients more than 80 years old was 7.8 %, and their 5YEARS was 51.6 %. Postoperative outcome of the patients with primary gastric carcinoma in Japan have apparently improved in advanced cases and among the aged population when compared with the archival data. Further efforts to improve the follow-up rate are needed.

Conclusions

Postoperative outcome of the patients with primary gastric carcinoma in Japan have apparently improved in advanced cases and among the aged population when compared with the archival data. Further efforts to improve the follow-up rate are needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, et al. Gastric cancer treated in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14:301–16.PubMedCrossRef Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, et al. Gastric cancer treated in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14:301–16.PubMedCrossRef
2.
go back to reference Japanese Gastric Cancer Association. Gastric cancer treatment guidelines for doctor’s reference (in Japanese). Kanehara: Tokyo; 2001. Japanese Gastric Cancer Association. Gastric cancer treatment guidelines for doctor’s reference (in Japanese). Kanehara: Tokyo; 2001.
4.
go back to reference Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence and mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. Lyon: IARC Press; 2004. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence and mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. Lyon: IARC Press; 2004.
5.
go back to reference Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, et al. Cancer incidence and incidence rates in Japan in 2002 based on data from 11 population-based cancer registries. Jpn J Clin Oncol. 2008;38:641–8.PubMedCrossRef Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, et al. Cancer incidence and incidence rates in Japan in 2002 based on data from 11 population-based cancer registries. Jpn J Clin Oncol. 2008;38:641–8.PubMedCrossRef
6.
go back to reference Higashi T, Sobue T, Nishimoto H. The current status of site-specific cancer registries in Japan. Surg Ther 2011;104(2):169–176 (in Japanese). Higashi T, Sobue T, Nishimoto H. The current status of site-specific cancer registries in Japan. Surg Ther 2011;104(2):169–176 (in Japanese).
7.
go back to reference Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:21–66. Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:21–66.
9.
go back to reference Survival rate in the member hospitals of the association of clinical cancer centers (diagnosed in 1997–2000). In: Kato H, Sobue T, Katanoda K, Saito Y, Tukuma H, Saruki N, et al., editors. Cancer statistics in Japan: 2008. Tokyo: Foundation for Promotion of Cancer Research; 2009. Survival rate in the member hospitals of the association of clinical cancer centers (diagnosed in 1997–2000). In: Kato H, Sobue T, Katanoda K, Saito Y, Tukuma H, Saruki N, et al., editors. Cancer statistics in Japan: 2008. Tokyo: Foundation for Promotion of Cancer Research; 2009.
Metadata
Title
Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry
Authors
Atsushi Nashimoto
Kohei Akazawa
Yoh Isobe
Isao Miyashiro
Hitoshi Katai
Yasuhiro Kodera
Shunichi Tsujitani
Yasuyuki Seto
Hiroshi Furukawa
Ichiro Oda
Hiroyuki Ono
Satoshi Tanabe
Michio Kaminishi
Publication date
01-01-2013
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2013
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-012-0163-4

Other articles of this Issue 1/2013

Gastric Cancer 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.